MarketFriction

Sangam Health Care Products Ltd

BSE 531625 · Medical Equipment & Supplies
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3.053.532.973.393.622.872.582.823.042.722.663.03
Expenses2.542.662.793.003.242.462.292.702.742.423.142.59
Operating Profit0.510.870.180.390.380.410.290.120.300.30-0.480.44
OPM %16.72%24.65%6.06%11.50%10.50%14.29%11.24%4.26%9.87%11.03%-18.05%14.52%
Other Income0.000.000.000.000.000.000.020.000.000.000.020.00
Interest0.000.010.010.000.000.000.010.000.000.000.000.00
Depreciation0.300.300.310.300.300.300.310.010.010.010.020.01
Profit before tax0.210.56-0.140.090.080.11-0.010.110.290.29-0.480.43
Tax %0.00%0.00%0.00%0.00%0.00%0.00%-1,900.00%9.09%17.24%34.48%-39.58%27.91%
Net Profit0.200.56-0.140.080.070.110.190.100.230.20-0.280.31
EPS in Rs0.130.38-0.090.050.050.070.130.070.150.13-0.190.21
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales23.7124.1620.9921.0421.819.548.7010.7612.1112.4611.2311.45
Expenses20.1924.5525.6220.0919.7810.869.1010.8810.6711.0010.9810.89
Operating Profit3.52-0.39-4.630.952.03-1.32-0.40-0.121.441.460.250.56
OPM %14.85%-1.61%-22.06%4.52%9.31%-13.84%-4.60%-1.12%11.89%11.72%2.23%4.89%
Other Income0.270.1218.410.472.930.020.000.000.000.020.020.02
Interest3.805.053.332.100.290.070.110.030.020.010.010.00
Depreciation1.531.521.521.501.261.221.221.221.221.220.060.05
Profit before tax-1.54-6.848.93-2.183.41-2.59-1.73-1.370.200.250.200.53
Tax %0.00%0.29%17.36%-6.88%-18.77%-11.20%-10.40%-14.60%-110.00%-76.00%75.00%
Net Profit-1.54-6.867.37-2.034.05-2.30-1.55-1.160.420.450.050.46
EPS in Rs-1.04-4.624.96-1.372.73-1.55-1.04-0.780.280.300.030.30
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth-7%3%1%-4%
Compounded Profit Growth7%15%27%-2%
Stock Price CAGR%%%%
Return on Equity%%%%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital14.8614.8614.8614.8614.8614.8614.8614.8614.8614.8614.8614.86
Reserves-31.81-33.35-37.85-28.59-34.83-30.78-33.08-34.63-35.79-35.37-34.92-34.71
Borrowings35.3736.0837.2717.2521.1517.5918.2123.4021.0819.3421.9821.93
Other Liabilities14.1515.1313.6518.6622.5911.299.435.467.927.679.429.14
Total Liabilities32.5732.7227.9322.1823.7712.969.429.098.076.5011.3411.22
Fixed Assets23.9422.6321.4419.9318.656.245.023.812.611.390.180.30
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets8.6310.096.492.255.126.724.405.285.465.1111.1610.92
Total Assets32.5732.7227.9322.1823.7712.969.429.098.076.5011.3411.22
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-16.80-0.37-4.44-5.9711.05-11.080.140.992.491.94-2.760.03
Cash from Investing Activity4.71-0.21-0.2918.70-1.0211.180.020.020.000.000.00-0.02
Cash from Financing Activity12.222.073.13-12.72-10.15-0.02-0.13-0.13-2.35-1.772.63-0.06
Net Cash Flow0.131.48-1.600.01-0.120.070.030.880.140.18-0.13-0.06
Free Cash Flow-16.84-0.58-4.78-5.9810.820.080.140.992.491.94-2.760.03
CFO/OP-419%-11%1,138%129%1,171%-546%-11%-248%-2,075%135%-189%12%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days3.732.000.910.176.078.3726.4025.5921.378.14106.04114.41
Inventory Days326.78257.49135.9321.81107.44137.4868.48133.10162.22100.8790.5678.77
Days Payable259.18286.44155.91127.48155.15219.37284.89191.42384.17358.59454.87479.65
Cash Conversion Cycle71.32-26.94-19.07-105.50-41.64-73.53-190.02-32.73-200.58-249.58-258.27-286.47
Working Capital Days-224.83-240.15-253.81-339.09-627.99-345.59-880.36-981.30-106.85-110.01-77.92-75.41
ROCE %37.12%12.55%-11.23%137.75%-3.40%259.65%-303.61%-89.50%-70.90%69.33%10.50%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters70.12%70.12%70.12%70.12%70.12%70.12%70.12%70.12%70.12%70.12%70.12%70.12%
DIIs8.43%8.43%8.43%8.43%8.43%8.43%8.43%8.43%8.43%8.43%8.43%8.43%
Public21.44%21.44%21.44%21.44%21.44%21.44%21.44%21.44%21.44%21.44%21.44%21.44%
No. of Shareholders640640640640640640640640640640640640

Fundamentals

Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE10.5 %
ROE%
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)-4%
Compounded Profit Growth (TTM)-2%
Standalone figures.
Profitability
Operating margin (excl. other income)2.23%
Operating margin (incl. other income)2.40%
EBITDA margin5.15%
Pre-tax margin4.63%
Net profit margin4.02%
Net margin, latest quarter10.23%
ROE-0.25%
ROCE10.50%
ROA0.44%
ROE, 3-year average-1.50%
ROCE, 3-year average39.92%
ROA, 3-year average3.75%
ROE, 5-year average1.87%
ROCE, 5-year average-20.14%
ROA, 5-year average-3.80%
ROIC (approx.)6.99%
Tax rate75.00%
Other income / net worth-0.10%
Growth
Sales growth (latest year)-9.87%
Profit growth (latest year)-88.89%
Sales CAGR, 3 years1.44%
Sales CAGR, 5 years3.32%
Sales growth QoQ13.91%
Sales growth YoY (latest quarter)7.45%
Profit growth YoY (latest quarter)210.00%
Per share
EPS (TTM)Rs 0.31
EPS (latest year)Rs 0.03
EPS (latest quarter)Rs 0.21
EPS, 3-year averageRs 0.21
EPS, 5-year averageRs -0.24
Book value per shareRs -13.36
Sales per shareRs 7.70
Cash flow per shareRs 0.02
Free cash flow per shareRs 0.02
Efficiency
Asset turnover1.00x
Fixed asset turnover37.43x
Inventory turnover7.38x
Inventory days49 days
Debtor days114 days
Debtors turnover3.19x
Creditor days480 days
Cash conversion cycle-286 days
Working capital days-75 days
Leverage
Total debtRs 22 Cr
Cash and bankRs 0 Cr
Net debtRs 22 Cr
Debt to equity-1.10x
Net debt / EBITDA36.92x
Interest coverage54.00x
Owners' fund to total sources-176.92%
Debt to assets195.45%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs -0 Cr
Sales to cash flow374.33x
Statement figures
Net sales (TTM)Rs 11 Cr
Net sales (latest year)Rs 11 Cr
Sales (latest quarter)Rs 3 Cr
Operating profit excl. other income (latest year)Rs 0 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 7 Cr
Total expenditure (latest year)Rs 11 Cr
Total income (latest year)Rs 11 Cr
Share capitalRs 15 Cr
ReservesRs -35 Cr
Shareholders' fundsRs -20 Cr
Total assetsRs 11 Cr
Net blockRs 0 Cr
ReceivablesRs 4 Cr
InventoryRs 1 Cr
Other liabilitiesRs 9 Cr
Shares outstanding (crore)1.49
Ownership
Promoter holding70.12% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 3 of 8
seriousNegative equity Shareholders' equity is negative
explainWeak cash conversion Cash from operations was -86% of net profit over the last 3 years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹3 Cr +7.4% vs Jun 2025. Net profit ₹0 Cr +210.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Poly Medicure Ltd16,67152.112.5 %
Molbio Diagnostics Ltd14,47066.618.0 %
Fischer Medical Ventures Ltd2,35596.211.4 %
Tarsons Products Ltd1,7541484.59 %
Q-Line Biotech Ltd1,56927.822.5 %
Laxmi Dental Ltd1,05830.415.0 %
Hemant Surgical Industries Ltd86951.318.9 %
Vasa Denticity Ltd75462.37.54 %
OSEL Devices Ltd69123.624.4 %
Prevest Denpro Ltd46220.524.9 %
QMS Medical Allied Services Ltd41939.012.9 %
Nureca Ltd34980.43.30 %
Aprameya Engineering Ltd20039.712.6 %
Avience Biomedicals Ltd19822.727.0 %
Earkart Limited17936.317.5 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Sangam Health Care Products Ltd?

Sangam Health Care Products Ltd (531625) has a market capitalisation of Rs Cr. at the close.

What were Sangam Health Care Products Ltd's latest quarterly results?

In the Jun 2026 quarter, Sangam Health Care Products Ltd sales was Rs 3 Cr (+7.4% vs Jun 2025) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03